Clinical Trials Browser

Phase 2 × Histone Deacetylase Inhibitors × Dermatologic × Clear all

NCT00185302 2015-12-14

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Phase 2 Completed

Melanoma